✦ LIBER ✦

Cystic fibrosis lung disease: The role of nitric oxide

✍ Scribed by Hartmut Grasemann; Felix Ratjen

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 47 KB
Volume: 28
Category: Article
ISSN: 8755-6863
DOI: 10.1002/(sici)1099-0496(199912)28:6<442::aid-ppul10>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased concentration of exhaled nitri

Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis

✍ H. Grasemann; E. Michler; M. Wallot; F. Ratjen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Nitric oxide (NO) is produced by various cell types in the human respiratory tract. Endogenously produced nitric oxide is detectable in the exhaled air of healthy individuals. Exhaled NO has been shown to be increased in airway inflammation, most probably due to cytokine-mediated activation of NO sy

Quality of life in patients awaiting lun

Quality of life in patients awaiting lung transplant: Cystic fibrosis versus other end-stage lung diseases

✍ Eileen J. Burker; Robert A. Carels; Laurie F. Thompson; Lynn Rodgers; Thomas Ega 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

Aerosolized dornase alfa in cystic fibro

Aerosolized dornase alfa in cystic fibrosis: Is there a role in the management of patients with early obstructive lung disease?

✍ David E. Geller 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Airway inflammation and infection are present in patients with mild lung disease in cystic fibrosis (CF), suggesting the need for early treatment. In a previously reported large multicenter trial, dornase alfa improved pulmonary function and decreased the need for hospitalization in patients with CF

Nitric oxide in the pathogenesis of vasc

Nitric oxide in the pathogenesis of vascular disease

✍ Li, Huige; F�rstermann, Ulrich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Nitric oxide (NO) is synthesized by at least three distinct isoforms of NO synthase (NOS). Their substrate and cofactor requirements are very similar. All three isoforms have some implications, physiological or pathophysiological, in the cardiovascular system. The endothelial NOS III is physiologica

Genotype-phenotype correlation in cystic

Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes

✍ Salvatore, Francesco ;Scudiero, Olga ;Castaldo, Giuseppe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Multicenter, open-label study of recombi

Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease

✍ H. Karsten Harms; Elias Matouk; Guy Tournier; Horst von der Hardt; Peter H. Well 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Cystic fibrosis is characterized by the accumulation of thick viscous purulent secretions. Recombinant human deoxyribonuclease I (rhDNase) breaks down extracellular DNA, which contributes to the increased viscosity of sputum. A multinational, open-label study was conducted in 974 cystic fibrosis pat